Recent Headlines
Within Pharmaceuticals
3D Map of PC2 to Jump-Start Drug Discovery Efforts in Polycystic Kidney Disease
Scientists from the Structural Genomics Consortium (SGC) and Oxford University report a three-dimensional view of the Polycystin-2 (PC2), a protein that causes autosomal dominant polycystic kidney disease (ADPKD) when mutated, in an article published this week in Nature Structural and Molecular... - December 21, 2016 - The SGC
IQ4I Research & Consultancy Published a New Report on "Implantable Biomaterials Global Market – Forecast to 2022"
A biomaterial may be natural or synthetically derived substance intended to interface with biological systems to evaluate, treat, augment, or replace any tissue, organ, or function of the body for a life time. The increasing aging population, demand for minimally invasive surgery, R&D, miniaturized implant is driving growth. - December 21, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Phi Life Sciences Launches Licensed Prostate Mitomic Test (PMT™) for Prostate Cancer Risk
Phi Life Sciences (Phi), a molecular diagnostic and laboratory service company that empowers physicians to deliver precision treatments and diagnostics to improve patient care and health, announced today that it has launched the Prostate Mitomic Test (PMT™) that is licensed from MDNA Life... - December 19, 2016 - Phi Life Sciences
QPS Bio-Kinetic Names Brendon Bourg Vice President and General Manager
QPS Bio-Kinetic, one of the largest independent Phase 1 Clinical Research Organization (CRO) facilities in the country, today announces the appointment of Brendon Bourg as Vice President and General Manager. Bourg will administer and monitor all aspects of the Phase 1 facility and report to Ben Chein, President and CEO of QPS Holdings, LLC. - December 19, 2016 - QPS Bio-Kinetic
Thrivous Joins the Tech Inclusion Pledge
Thrivous, a human enhancement company, has joined the Tech Inclusion Pledge as announced by President Obama. At the Global Entrepreneurship Summit this past summer, President Obama announced a commitment by senior leadership from 33 companies of all sizes to fuel American innovation and economic... - December 18, 2016 - Thrivous
Pcdata USA Expansion – Office Moved
Pcdata USA moved to new location on 29 Kripes Road in East Granby, CT adding new team members and managing growing product flow. - December 18, 2016 - Pcdata USA
SnooZeal, the Ground-Breaking Phone Controlled Anti-Snoring Device That Gives Your Tongue a Workout and Treats the Cause of Snoring/Sleep Apnea
SnooZeal is the world’s first over the counter smart phone controlled anti-snoring/sleep apnoea medical device aimed at reversing the root cause of snoring and obstructive sleep apnoea. The app, used in conjunction with the device, works like a Fit Bit for snoring, keeping users on track and... - December 16, 2016 - Snoozeal
Fierce Innovation Awards: Life Sciences Edition Announce Finalists, Innovative Biochips Recognized
Innovative Biochips LLC has been selected as a finalist in Fierce Innovation Awards 2016 for its innovative product, Automated Yeast Aging Analysis System. - December 15, 2016 - Innovative Biochips
Annual Healthcare Trends Survey: ACA Anxieties Aside, Majority Well Positioned for Value-Based Reimbursement in 2017
The realm of value-based reimbursement wielded the most influence over the business of healthcare in 2016, according to the thirteenth annual industry trends snapshot by the Healthcare Intelligence Network (HIN). - December 14, 2016 - Healthcare Intelligence Network
IQ4I Research & Consultancy Published a New Report on “Ultrasound medical devices Global Market – Forecast To 2023”
Ultrasound is a kind of imaging technique/procedure that makes use of high-frequency sound waves for scanning and creating an image of body part. Due to its less cost, best imaging quality, workflow efficiency, reliability, no requirement of same computing power, fast frame rates or specialized transducers now-a-days ultrasound scans are most popularly used diagnostic imaging technique. - December 14, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Europital Introduced PenThu® at the Clinical Operations in Oncology Trials Event
Europital participated at the “Clinical Operations in Oncology Trials Europe 2016” that was held the 29th and 30th of November in Amsterdam, in which PenThu® was officially introduced to all professionals attendees. - December 14, 2016 - Europital BVBA
Pcdata USA is Expanding - Adding Sales and Operations Staff
"Pcdata USA will close 2016 for the 6th consecutive year growing its top line sales," says Marc Braun, president of Pcdata’s North American operations, "and adding staff to keep up with current and projected demand for our products and solutions is the right thing to do." - December 14, 2016 - Pcdata USA
Bioscience Americas Lauds Passage of the 21st Century Cures Act
President Obama is expected to sign this landmark bi-partisan legislation soon. - December 13, 2016 - Bioscience Americas
Pet Insurance Association Appoints Susan McManus as President
The North American Pet Health Insurance Association (NAPHIA) recently elected Susan McManus as the association’s new President, by special vote. - December 13, 2016 - NAPHIA - North American Pet Health Insurance Association
Gatekeeper Innovation's Safer Lock Locking Prescription Bottles Now Sold at Lowe's
Retail giant Lowe's is helping prevent prescription drug abuse by carrying Safer Lock locking prescription bottles; $14.99. Look for Safer Lock in the Child Safety Area of the Hardware Department in 58 Lowe's stores in California, Oregon, and Washington. Safer Lock is also sold online nationwide... - December 09, 2016 - Gatekeeper Innovation
Population Health Alliance Announces 2017 Board of Directors
Population Health Alliance (PHA), a leading non-profit organization dedicated to advancing the principles of population health, recently announced that four new members and one honorary member have been appointed to its Board of Directors. PHA members approved the appointments at the PHA Forum 2016... - December 09, 2016 - Population Health Alliance
Stem Cells Can Successfully Treat Patients with Type 1 Diabetes
The Bioscience Americas science team has a 5-year, 76% remission rate treating Type 1 diabetes using a patient's own stem cells. - December 08, 2016 - Bioscience Americas
December 15, 2016 Webcast to Spotlight Intensive Care Coordination for Healthcare Super Utilizers to Stabilize Medically Vulnerable Homeless Patients
Learn how Chronic Care Plus, a joint venture recuperative care program in California for medically vulnerable chronically homeless patients, saved $2.8 million yearly over two years while providing community-based stabilization during a December 15, 2016 webcast sponsored by the Healthcare Intelligence Network. - December 08, 2016 - Healthcare Intelligence Network
The Cardiac & Vascular Institute Research Foundation to Participate in National Institutes of Health TACT2 Research Trial
Second study will focus on benefits of removing toxic metal pollutants in patients with diabetes and a prior heart attack. - December 07, 2016 - The Cardiac & Vascular Institute
Hometown Urgent Care Supporting Local Community with Multi-Location Food Drive Through December 15
Hometown Urgent Care Continues Efforts to Support Local Community.. - December 07, 2016 - Hometown Urgent Care
University of Malaga Researchers Collaborate with AST to Develop New Lignin-Based Products
AST to send multiple shipments of its Organosolv lignin for continued product development efforts. - December 07, 2016 - American Science and Technology
Life Science Leader and ClinicalLeader.com Announce New Forum for Small to Mid-Sized Pharma and Biotech Companies
Life Science Leader and ClinicalLeader.com are excited to introduce Clinical Leader Forum, a new conference tailored just for executives at pharma and biotech sponsor companies that rely on contract research organizations for clinical trials. The inaugural event is scheduled for May 10 through 11... - December 07, 2016 - Clinical Leader Forum
Global Human Insulin Market USD 32.8 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.
The global human insulin market is estimated to reach USD 32.8 Billion in 2020, expanding at a CAGR of 4.8% from 2016 to 2020, published by iHealthcareAnalyst, Inc. - December 04, 2016 - iHealthcareAnalyst, Inc.
Global Minimally Invasive Surgery Market USD 9.8 Billion by 2020, Published by iHealthcareAnalyst, Inc.
The global minimally invasive surgery market is estimated to reach USD 9.8 Billion in 2020, growing at a CAGR of 6.4% from 2016 to 2020, published by iHealthcareAnalyst, Inc. Visit the Minimally Invasive Surgery Market – Surgical Devices (Ablation Devices, Radiofrequency Ablation, Microwave... - December 04, 2016 - iHealthcareAnalyst, Inc.
ITSENCLOSURES Introduces the IceStation Titan NEMA 4 Computer Enclosure to Impressive Product Lineup
ITSENCLOSURES is proud to add to the popular IceStation TITAN family of computers enclosures with the new NEMA 4 freestanding computer enclosure. - December 03, 2016 - ITSENCLOSURES
Mantality Donates $2,500 to Des Moines Police Officers' Credit Union
Low testosterone treatment centers support area's fallen officers. - December 02, 2016 - Mantality
Detectamet Marks the First Year of Success in the USA
Thirteen months since opening in Richmond VA, Detectamet Inc has passed a $1 million turnover. To mark the achievement the company has launched an award scheme that recognises a Food Production company’s demonstration of a positive food safety culture. The Guardian award is issued annually as a Silver, Gold or Platinum certificate depending on the level of commitment. - December 02, 2016 - Detectamet
New Research Explores Wearable Technology Utilization in Clinical Trials and the Role of CROs
New Report Identifies Current and Future Wearable Technology Utilization and CRO Implications with 130 Clinical Outsourcing Decision Makers. - December 01, 2016 - Life Science Strategy Group, LLC
Global Nonalcoholic Steatohepatitis Treatment (Phase III Drugs) Market USD 19.8 Billion by 2025 - iHealthcareAnalyst, Inc.
The global nonalcoholic steatohepatitis treatment (Phase III Drugs) market is estimated to reach USD 19.5 Billion in 2025, expanding at a CAGR of 10.0% from 2016 to 2025, published by iHealthcareAnalyst, Inc. Visit the Nonalcoholic Steatohepatitis Treatment Market – Phase III Drugs In... - December 01, 2016 - iHealthcareAnalyst, Inc.
Global Hospital-Acquired Pneumonia Drugs (Phase III) Market USD 3.8 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.
The global hospital-acquired pneumonia drugs (Phase III) market is estimated to reach USD 3.8 Billion in 2020, published by iHealthcareAnalyst, Inc. Visit the Hospital-Acquired Pneumonia Drugs (Phase III) Market – Amikacin Inhale, Ceftazidime (Avibactum), Ceftolozane (Tazobactam),... - December 01, 2016 - iHealthcareAnalyst, Inc.
Global Casting and Splinting Equipment Market USD 2.2 Billion by 2020, Published by iHealthcareAnalyst, Inc.
The global casting and splinting equipment market growing at the rate of 5.3% CAGR estimated to reach USD 2.2 Billion by 2020 due to higher preference for minimal invasive technologies and rising geriatric population worldwide, published by iHealthcareAnalyst, Inc. - December 01, 2016 - iHealthcareAnalyst, Inc.
Galen Dean Tapped for National Nursing Leadership Program
Galen College of Nursing’s Dean, Tara Dailey, has been accepted into the 2017 National League of Nursing LEAD program. The program is a part of the NLN’s Leadership Institute in the Center for Transformational Leadership. The LEAD program is an invitation only program for leaders in... - November 30, 2016 - Galen College of Nursing
Research to be Presented at ASH Annual Meeting Shows Verseon’s New Class of Anticoagulants Prevents Thrombosis While Preserving Platelet Function
Verseon’s anti coagulants are as effective as NOACS at preventing arterial and venous thromboembolism and thrombin-induced pulmonary embolism. Lead candidate has low renal clearance compared to NOACS - highly desirable for patients with impaired renal function. - November 30, 2016 - Verseon
Digital Health Startup Vitalistics Announces Public Launch
Vitalistics, a digital health startup transforming the overnight pulse oximetry and home sleep testing experience, launches today. - November 30, 2016 - Vitalistics
Global Anti-Aging Products and Services Market USD 300 Billion by 2020, Published by iHealthcareAnalyst, Inc.
Anti-Aging Products and Services Market – Product Types (Anti-Stretch Marks, Anti-Wrinkle, Botox, Dermal Fillers, Hair Color, UV Absorbers), Device Type (Anti-Cellulite Treatment, Laser Aesthetics, Microderm Abrasion, and Radiofrequency Devices), Service Types (Abdominoplasty, Adult Acne Therapy, Anti-Pigmentation Therapy, Breast Augmentation, Chemical Peel, Eye-Lid Surgery, Hair Restoration, Liposuction, and Sclerotherapy) 2016-2020 - November 30, 2016 - iHealthcareAnalyst, Inc.
Global Medical Imaging Reagents Market USD 19.7 Billion by 2020 - iHealthcareAnalyst, Inc.
Medical Imaging Equipment Market – Product Types (Computed Tomography Scanners, Magnetic Resonance Imaging Equipment, Nuclear Imaging Equipment – PET, SPECT, Ultrasound Systems, X-Ray Devices) and Technologies (Computed Tomography Scanners, Magnetic Resonance Imaging Equipment, Nuclear Imaging Equipment – PET, SPECT, Ultrasound Systems – 2D, 3D, 4D, Doppler, High Intensity Frequency Ultrasound, Lithotripsy, X-Ray Devices – Analog, Computed, Digital Radiography) 2016-2020. - November 30, 2016 - iHealthcareAnalyst, Inc.
Global Bag Valve Masks Market USD 100 Million by 2020, Research Study by iHealthcareAnalyst, Inc.
The global bag value masks market by Product Types (BVM Disposable and BVM Reusable) 2016-2020 is estimated to reach USD 100 Million in 2020, growing at a CAGR of 5.2% from 2016 to 2020, published by iHealthcareAnalyst, Inc. - November 30, 2016 - iHealthcareAnalyst, Inc.
Global Dental Consumables Market USD 25.7 Billion by 2020, Published by iHealthcareAnalyst, Inc.
The global dental consumables market to reach nearly USD 25.7 Billion in 2020, at a CAGR of 6.8% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Dental Consumables Market Analysis and Forecast 2016-2020 report https://www.ihealthcareanalyst.com/report/dental-consumables-market/. Dental... - November 29, 2016 - iHealthcareAnalyst, Inc.
Global Autoimmune Disease Diagnostics Market USD 14.8 Billion by 2020, Market Study by iHealthcareAnalyst, Inc.
The global autoimmune disease diagnostics market was valued at USD 12.4 Billion in 2015 and is estimated to reach USD 14.8 Billion by 2020, at a CAGR of 3.6% from 2016 to 2020 - iHealthcareAnalyst, Inc. Browse the Autoimmune Disease Diagnostics Market Analysis and Forecast 2016-2020 at https://www. - November 29, 2016 - iHealthcareAnalyst, Inc.
Global Anesthesia Devices Market USD 9.6 Billion by 2020 - iHealthcareAnalyst, Inc.
The global anesthesia devices market was valued at USD 6.3 Billion in 2015 and is estimated to reach USD 9.6 Billion by 2020, at a CAGR of 8.8% from 2016 to 2020 - iHealthcareAnalyst, Inc. Browse the Anesthesia Devices Market Analysis and Forecast 2016-2020 at... - November 29, 2016 - iHealthcareAnalyst, Inc.
Social Determinants and Population Health: Moving Beyond Clinical Data in a Value-Based Healthcare System, December 8, 2016 Webinar
A December 8, 2016 webcast from the Healthcare Intelligence Network will examine opportunities available to healthcare providers to improve population health by going beyond traditional clinical factors to identify the social determinants impacting a person's health. - November 28, 2016 - Healthcare Intelligence Network
Global Cancer Technology, Inc. Signs Licensing Agreement with the University of California San Diego
Announcing an agreement to purchase patent and IP technology from UCSD for a novel way to track medical instruments using Nano Quantum Dots - November 25, 2016 - Global Cancer Technology, Inc
Forum for Drug Sponsors and Contract Development and Manufacturing Professionals Completes 2016 Program and Returns to Boston, San Diego and San Francisco in 2017
Outsourced Pharma’s final program in 2016 was recently concluded in San Francisco. For the first time, technology companies, venture capital firms and others from Silicon Valley and elsewhere were invited to join the Outsourced Pharma community to focus on the topic of “Drug Development... - November 25, 2016 - Outsourced Pharma Events
DelveInsight Announces End of the Year Discount on Reports
DelveInsight, a leading market research and consulting company, is offering discounts on its market research reports. - November 25, 2016 - DelveInsight
Zifo RnD Solutions Ranked Number 40 Fastest Growing Technology Company on the Deloitte Technology Fast 50™ India 2016
Attributes its 146% revenue growth to the Zifo team’s collective strength and commitment towards customer’s success. - November 23, 2016 - Zifo
Arch, Inc. and ROWhy Company Announce Toward Zero Co.
With the combined resources of Arch and ROWhy, Toward Zero Co., is ideally positioned to help move customers toward zero waste and tangible profit growth through integration of business and manufacturing systems with automation technology. - November 23, 2016 - Arch, Inc
Mayne Pharma Launches Temozolomide Capsules in U.S. – Generic Alternative to Temodar®
Mayne Pharma Inc. (Mayne Pharma) is pleased to announce the U.S. launch of temozolomide capsules, 5mg, 20mg, 100mg, 140mg, 180mg and 250mg, which is a generic version of branded Temodar®. Temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed cancerous... - November 23, 2016 - Mayne Pharma USA
ALFA Scientific Designs, Inc. Launches Redesigned Website to Drive User Experience
A leader in rapid, point-of-care (POC) in-vitro diagnostic (IVD) device developer and manufacturer, ALFA Scientific Designs, Inc. has launched a newly redesigned website to better serve its customers. With updated modules, attention to user experience, and a clear design, ALFA has launched a... - November 22, 2016 - Alfa Scientific Designs
It’s What You Need: NAPHIA Releases 2016 Industry Insiders’ Report
This latest version of Industry Insiders’ Report is full of exclusive research, market metrics and private data from NAPHIA’s 2016 State of the Industry Report, as well as never-before shared gross written premiums from individual NAPHIA member-companies. This is information on companies and their performance that is not available anywhere else. - November 22, 2016 - NAPHIA - North American Pet Health Insurance Association
Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults
A new transdermal gel has been developed and is now available by prescription only to treat the symptoms of gout attacks. ColciGel® is a transdermal medication that provides rapid relief of pain at the first sign of acute gout flares without gastrointestinal problems. - November 22, 2016 - Gensco Pharma